Citigroup has adjusted its price target for Xylem (XYL) to $174, down from $182, while reiterating a Buy rating on the stock. This update comes amidst several other analyst adjustments for Xylem on the same day, reflecting a general reassessment of the company’s valuation by financial institutions.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Citigroup Adjusts Price Target on Xylem to $174 From $182, Maintains Buy Rating
Citigroup has adjusted its price target for Xylem (XYL) to $174, down from $182, while reiterating a Buy rating on the stock. This update comes amidst several other analyst adjustments for Xylem on the same day, reflecting a general reassessment of the company’s valuation by financial institutions.